Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Pannuti

Showing results (21-30 of 96) with videos related to

Pageof 10
Sort By:
Journal of Chemotherapy (Florence, Italy)|October 1, 1992
The antiemetic efficacy and the cost-benefit ratio of ondansetron calculated with a new approach to health technology assessment (real cost-benefit index)S Tanneberger, G Lelli, A Martoni, et al.
American Journal of Clinical Oncology|October 22, 1998
The combination of paclitaxel and carboplatin as first-line chemotherapy in patients with stage III and stage IV ovarian cancer: a phase I-II studyC Zamagni, A Martoni, N Cacciari, et al.
Cancer Treatment Reports|November 1, 1984
4'-epi-doxorubicin in combination with cisplatin in advanced ovarian cancerA Martoni, L Tomasi, G Farabegoli, et al.
Journal of Chemotherapy (Florence, Italy)|December 1, 1990
A phase II study on lonidamine combined with cisplatin and etoposide in the treatment of advanced non-small cell bronchogenic carcinoma (NSCBC)G Lelli, M Guaraldi, N Canova, et al.
Journal of Chemotherapy (Florence, Italy)|February 1, 1993
A phase II study of carboplatin and cyclophosphamide in advanced ovarian carcinomaA Martoni, A Panetta, B Angelelli, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 1, 1992
A phase II study of high-dose epirubicin plus cisplatinum in advanced non-small-cell lung cancer (NSCLC)A Martoni, M Guaraldi, M Casadio, et al.
Clinical Lung Cancer|December 6, 2003
Phase II study of sequential treatment of advanced non-small-cell lung cancer: three cycles of high-dose epirubicin plus cisplatin followed by weekly vinorelbineM Guaraldi, A Marino, F Pannuti, et al.
Journal of Chemotherapy (Florence, Italy)|June 1, 1989
A randomized clinical trial with a weekly regimen of 5-fluorouracil with or without folinic acid in advanced gastrointestinal adenocarcinomas: a preliminary reportA Martoni, A Cricca, M Guaraldi, et al.
Chemioterapia : International Journal of the Mediterranean Society of Chemotherapy|August 1, 1986
Medroxyprogesterone acetate plasma levels after a single oral administration of two drug formulationsF Pannuti, E Strocchi, A Longhi, et al.
Advances in Gerontology = Uspekhi Gerontologii|February 13, 2003
New challenges and old problems: end of life care and the dilemma of prognostic accuracyK S Tanneberger, F Pannuti, I Malavasi, et al.
Pageof 10

Showing results (21-30 of 96) with videos related to

Sort By:
Pageof 10
Journal of Chemotherapy (Florence, Italy)|October 1, 1992
The antiemetic efficacy and the cost-benefit ratio of ondansetron calculated with a new approach to health technology assessment (real cost-benefit index)S Tanneberger, G Lelli, A Martoni, et al.
American Journal of Clinical Oncology|October 22, 1998
The combination of paclitaxel and carboplatin as first-line chemotherapy in patients with stage III and stage IV ovarian cancer: a phase I-II studyC Zamagni, A Martoni, N Cacciari, et al.
Cancer Treatment Reports|November 1, 1984
4'-epi-doxorubicin in combination with cisplatin in advanced ovarian cancerA Martoni, L Tomasi, G Farabegoli, et al.
Journal of Chemotherapy (Florence, Italy)|December 1, 1990
A phase II study on lonidamine combined with cisplatin and etoposide in the treatment of advanced non-small cell bronchogenic carcinoma (NSCBC)G Lelli, M Guaraldi, N Canova, et al.
Journal of Chemotherapy (Florence, Italy)|February 1, 1993
A phase II study of carboplatin and cyclophosphamide in advanced ovarian carcinomaA Martoni, A Panetta, B Angelelli, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 1, 1992
A phase II study of high-dose epirubicin plus cisplatinum in advanced non-small-cell lung cancer (NSCLC)A Martoni, M Guaraldi, M Casadio, et al.
Clinical Lung Cancer|December 6, 2003
Phase II study of sequential treatment of advanced non-small-cell lung cancer: three cycles of high-dose epirubicin plus cisplatin followed by weekly vinorelbineM Guaraldi, A Marino, F Pannuti, et al.
Journal of Chemotherapy (Florence, Italy)|June 1, 1989
A randomized clinical trial with a weekly regimen of 5-fluorouracil with or without folinic acid in advanced gastrointestinal adenocarcinomas: a preliminary reportA Martoni, A Cricca, M Guaraldi, et al.
Chemioterapia : International Journal of the Mediterranean Society of Chemotherapy|August 1, 1986
Medroxyprogesterone acetate plasma levels after a single oral administration of two drug formulationsF Pannuti, E Strocchi, A Longhi, et al.
Advances in Gerontology = Uspekhi Gerontologii|February 13, 2003
New challenges and old problems: end of life care and the dilemma of prognostic accuracyK S Tanneberger, F Pannuti, I Malavasi, et al.
Pageof 10